Clinical trial
Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic…
NCT00464971 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00464971 |
|---|---|
| Title | Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial |
| Official title | Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Estrogen Deficiency-Derived Atrophic Vaginitis |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Menopause, Postmenopausal Vaginal Atrophy |
| Intervention type | Drug |
| Interventions | estradiol, 25 mcg |
| Enrollment | 102 |
| Start date | Jan 31, 1995 |
| Primary completion | Nov 30, 1996 |
| Completion | Nov 30, 1996 |
| First posted | Apr 24, 2007 |
| Last update posted | Mar 1, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: